Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Vestibular
Interventions
DRUG

Promethazine

Subject receives promethazine

BEHAVIORAL

Hyper gravity training

Subject receives hypergravity training before testing

DRUG

Placebo

Placebo

BEHAVIORAL

No hypergravity training

Subjects do not receive normal Earth gravity

Trial Locations (1)

02114

Massachusetts Eye and Ear Infirmary, Boston

All Listed Sponsors
collaborator

National Space Biomedical Research Institute

OTHER

collaborator

Massachusetts Institute of Technology

OTHER